NCT06835855 Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression
| NCT ID | NCT06835855 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Binghamton University |
| Condition | Depression - Major Depressive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 225 participants |
| Start Date | 2024-11-14 |
| Primary Completion | 2029-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 225 participants in total. It began in 2024-11-14 with a primary completion date of 2029-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to examine attentional biases for facial displays of emotion as a mechanism of risk in infants of mothers with postpartum major depression, and the potential role of infant arousal in the development of these attentional biases.
Eligibility Criteria
Inclusion Criteria: * The high-risk group (n = 150) will consist of women with at least one episode of MDD since their baby's birth. * To qualify for the low-risk group (n = 75), women cannot have a history of any depressive disorder or any current psychiatric diagnoses. * Infants will be required to be singleton children born full-term (\> 37 weeks) and normal weight (\> 2,500 grams) with no birth complications or health problems to avoid medical complications contributing to infants' attention, reactivity, and regulation measures. * The two groups will be matched on demographic factors (e.g., age, race/ethnicity, income). Exclusion Criteria: * Additional exclusion criteria are diagnoses of alcohol or substance use disorders currently or at any point during pregnancy, or lifetime history of bipolar or psychotic disorders.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06835855 clinical trial?
This trial is open to participants of all sexes, aged 6 Months or older, studying Depression - Major Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06835855 currently recruiting?
Yes, NCT06835855 is actively recruiting participants. Contact the research team at bgibb@binghamton.edu for enrollment information.
Where is the NCT06835855 trial being conducted?
This trial is being conducted at Binghamton, United States.
Who is sponsoring the NCT06835855 clinical trial?
NCT06835855 is sponsored by Binghamton University. The trial plans to enroll 225 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.